GlassScriptPhysician profile
Jessie Ho
NPI 1336643758
$7,134.74
in general payments reported to CMS, 2019-2025
11 companies · $1,157 in 2025
The $1,157 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.92 · 2021: $5,092 · 2022: $94.12 · 2023: $256 · 2024: $459 · 2025: $1,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,428 · Education: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,427.97 |
| Education | $444.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,207.10 | 2021-2025 | Signia |
| W. L. Gore & Associates, INC. | $1,225.83 | 2021-2025 | Gore Viabahn Endoprosthesis With Heparin, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Endoprosthesis |
| Shockwave Medical, INC | $161.61 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $148.46 | 2025 | Artix Mt |
| Davol INC. | $123.17 | 2025 | Arista |
| Conmed Corporation | $76.92 | 2019 | |
| Terumo Medical Corporation | $64.47 | 2024 | Azur Cx Detachable |
| Baxter Healthcare | $46.01 | 2023 | Perclot |
| Boston Scientific Corporation | $37.36 | 2025 | Enroute Transcarotid Neuroprotection System |
| Olympus America INC. | $26.49 | 2024 | Soltive |
| Intuitive Surgical, INC. | $17.32 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessie Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.